Editorial
doi: 10.1001/jama.2018.7906.
Abortion-Related Adverse Events by Facility Type: Reassurance From a National Analysis
Affiliations
- PMID: 29946708
- DOI: 10.1001/jama.2018.7906
Item in Clipboard
Editorial
Abortion-Related Adverse Events by Facility Type: Reassurance From a National Analysis
JAMA.
.
No abstract available
Comment on
-
Association of Facility Type With Procedural-Related Morbidities and Adverse Events Among Patients Undergoing Induced Abortions.JAMA. 2018 Jun 26;319(24):2497-2506. doi: 10.1001/jama.2018.7675. JAMA. 2018. PMID: 29946727 Free PMC article.
Similar articles
-
US federal court upholds limits on abortion drug mifepristone.BMJ. 2023 Aug 21;382:1924. doi: 10.1136/bmj.p1924. BMJ. 2023. PMID: 37604517 No abstract available.
-
Risks of and Indications for Mifepristone for Medication Abortion.Am Fam Physician. 2022 Jan 1;105(1):5-6. Am Fam Physician. 2022. PMID: 35029956 No abstract available.
-
Introducing medication abortion into public sector facilities in KwaZulu-Natal, South Africa: an operations research study.Contraception. 2015 Oct;92(4):330-8. doi: 10.1016/j.contraception.2015.07.001. Epub 2015 Jul 7. Contraception. 2015. PMID: 26162575
-
Clinical applications of mifepristone.Gynecol Endocrinol. 2006 Dec;22(12):655-9. doi: 10.1080/09513590601005946. Gynecol Endocrinol. 2006. PMID: 17162706 Review.
-
Second trimester medical abortion with mifepristone-misoprostol and misoprostol alone: a review of methods and management.Reprod Health Matters. 2008 May;16(31 Suppl):162-72. doi: 10.1016/S0968-8080(08)31371-8. Reprod Health Matters. 2008. PMID: 18772097 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
